Thomas RizzoEDUCATION
Ph.D., Chemistry, University of Wisconsin, Madison, 1983
B.S., Chemistry, cum laude, Rensselaer Polytechnic Institute, 1978
ACADEMIC AND ADMINISTRATIVE POSITIONS
Dean, Faculty of Basic Sciences, EPFL, 2004-present
Head, Department of Chemistry, EPFL, 1997-2004
Professor of Chemistry, EPFL, 1994-present
Professor of Chemistry, University of Rochester, 1993-1994
Assistant Professor of Chemistry, University of Rochester, 1986-1992
Research Associate, The James Franck Institute, University of Chicago, 1984-1986
Bruno Emanuel Ferreira De Sousa CorreiaThroughout my PhD and postdoctoral studies I was trained in world-renowned laboratories and institutions in the United States of America (University of Washington and The Scripps Research Institute). Very early in my scientific career I found out my fascination about protein structure and function. My PhD studies evolved in the direction of immunogen design and vaccine engineering which sparked my interest in the many needs and opportunities in vaccinology and translational research. My efforts resulted in an enlightening piece of work where for the first time, computationally designed immunogens elicited potent neutralizing antibodies. During my postdoctoral studies I joined a chemical biology laboratory at the Scripps Research Institute. In this stage I developed novel chemoproteomics methods for the identification of protein-small molecule interaction sites in complex proteomes. In March 2015, I joined the École Polytechnique Fédérale de Lausanne (EPFL) – Switzerland as a tenure track assistant professor. The focus of my research group is to develop computational tools for protein design with particular emphasis in applying these strategies to immunoengineering (e.g. vaccine and cancer immunotherapy). The activities in my laboratory focus on computational design methods development and experimental characterization of the designed proteins. Our laboratory has been awarded with 2 prestigious research grants from the European Research Council. Lastly, I have been awarded the prize for best teacher of Life sciences in 2019.
Hilal Lashuel2012-2013 Visiting Professor, Standford University. Stanford School of Medicine
2011- Associate Professor of Life Sciences-Brain Mind Institute-EPFL
Dir. Laboratory of Chemical Biology of Neurodegeneration
2005-2011 Assistant Professor of Life Sciences-Brain Mind Institute-EPFL
Dir. Laboratory of Molecular Neurobiology and Neuroproteomics
2005-2008 Director- EPFL Proteomic Core Facility
2002-2004 Instructor of Neurology- Harvard Medical School and Brigham and Women's
Hospital
2001-2002 Sabbatical Fellow- Laboratory for Drug Discovery in Neurodegeneration
Harvard Medical School,
2001-2002 Post-doctoral Fellow- Center for Neurologic Diseases
Harvard Medical School and Brigham and Women's Hospital
Advisor- Prof. Peter T. Lansbury
2000-2001 Research Scientist, The Picower Institute for Medical Research, Great Neck
New York
1994-2000 PhD Student; Texas A&M University and the Scripps Research Institute
Advisor- Prof. Jeffery W. Kelly
1990-1994 B.S. City University of New York, Brooklyn College
Dr. Hilal A. Lashuel received his B.Sc. degree in chemistry from the City University of New York in 1994 and completed his doctoral studies at Texas A&M University and the Scripps Research Institute in 2000. After obtaining his doctoral degree, he became a research fellow at the Picower Institute for Medical Research in Long Island New York. In 2001, he moved to Harvard Medical School and the Brigham and Women's Hospital as a research fellow in the Center for Neurologic Diseases and was later promoted to an instructor in neurology at Harvard Medical School. During his tenure (2001-2004) at Harvard Medical School his work focused on understanding the mechanisms of protein misfolding and fibrillogenesis and the role of these processes in the pathogenesis of Parkinson's and Alzheimer's disease. In 2005 Dr. Lashuel moved Switzerland to join the Brain Mind Institute at the Swiss Federal Institute of Technology Lausanne as a tenure-track assistant professor in neurosciences. Currently, Dr. Lashuel is an associate professor of life sciences and the director of the laboratory of molecular and chemical biology of neurodegeneration. (http://lashuel-lab.epfl.ch/).
Research efforts in the Lashuels laboratory focus on understanding the molecular mechanisms of neurodegeneration and developing novel strategies to diagnose and treat neurodegenerative diseases such as Alzheimers and Parkinsons disease. Research in the Lashuel lab is funded by several international funding agencies and foundations, including the Swiss National Science Foundation, European FP7 program (Marie Curie and ERC grants), Human Science Frontiers, Strauss Foundation, Cure the Huntingtons disease foundation and Michael J Fox foundation and is supported by collaborations with pharmaceutical and biotech companies (http://lashuel-lab.epfl.ch/page-50538-en.html), Nestle, Merck-Serono, AC Immune and Johnson and Johnson.
Dr. Lashuels research has resulted in the characterization of novel quaternary structure intermediates on the amyloid pathway, identification of potential therapeutic targets, and new hypotheses concerning the mechanisms of pathogenesis in Alzheimers disease, Parkinsons disease and related disorders. Dr. Lashuel scientific contribution to this field includes i) more than100 publications in major peer reviewed journals including Nature journals, Cell, PNAS, JBC, J. Neuroscience JACS, and Angewandtie Chemie; ii) three patents on novel strategies for preventing protein aggregation and treating autoimmune and inflammatory diseases; iii) more than 150 invited lectures since 2002 and more than 5500 citations (7800 citation-Google Scholar) since 1996. Dr. Lashuel has received several pre-doctoral and post-doctoral awards and fellowships and was the recipient of two prestigious awards given to young investigators; Human Science Frontiers young investigator research award and the European Research Council (ERC) starting independent researcher grant and the ERC proof of concept award (2013) These awards provide more than $2.5 Million to Dr. Lashuel to translate some of his ideas and projects into novel strategies for diagnosing and treating neurodegenerative diseases such as Alzheimers and Parkinsons disease. Dr. Lashuel has chaired and co-organized several international conferences and serves as an academic editor for PLoS ONE, an associate editor for frontiers of molecular neuroscience, member of the Editorial advisory board of ChemBioChem and ad hoc reviewer for several international scientific journals and funding agencies. John MaddocksCitoyen de Grande Bretagne, John Maddocks est né en 1958. Il a obtenu un diplôme en mathématiques en 1978, à l'Université de Glasgow (Ecosse), ainsi qu'un doctorat à l'Université d'Oxford (Angleterre) en 1981. Sa thèse concernait la bifurcation et l'échange de stabilité dans les principes variationnels contraints qui apparaissent en théorie de l'élasticité. Il a ensuite effectué des travaux de recherche à l'Université de Stanford (USA), puis à Oxford, avant de rejoindre l'Université du Maryland (USA) en 1984. Il y est nommé professeur associé en 1989, puis professeur ordinaire en 1993. Il a notamment été chercheur invité à l'Université du Minnesota, du Texas, de Heriot-Watt, d'Oxford, à l'Institut Courant à New York et à l'École polytechnique fédérale de Zurich.
Ses travaux de recherche concernent principalement l'analyse et les techniques computationnelles en mécanique non linéaires.Il a effectué des travaux interdisciplinaires faisant intervenir différents domaines, tels la robotique, la dynamique des satellites et l'étude de macromolécules comme l'ADN. Il est spécialiste de la théorie de la stabilité des systèmes hamiltoniens et des phénomènes de bifurcation dans les problèmes de calcul des variations paramétrés. Plus récemment, il a mis au point des outils de calcul scientifique interactifs qui utilisent des techniques de visualisation avancées.
En juin 1997, il est nommé professeur ordinaire en analyse appliquée, au Département de mathématiques. Il enseigne en particulier l'analyse et des cours plus spécialisés aux ingénieurs et ingénieurs mathématiciens. Il continuera à effectuer des travaux de recherche en mécanique du continu, en techniques de visualisation, en analyse et en calcul scientifique.
